Skip to main content
Figure 6 | Journal of Negative Results in BioMedicine

Figure 6

From: Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts

Figure 6

Percentages of tumors from the CNS9204 cohort for which each neuropathologist's independent grade assignment (phase 1) matched the consensus grade after joint review by all pathologists (phase 2); e.g. pathologist A independently classified 22/84 tumors as grade II and 62/84 tumors as grade III during phase 1, while in phase 2, joint review classified 17/22 and 54/62 as grade II and grade III tumors, respectively, producing an overall "match" on 71/84 tumors.

Back to article page